Statin therapy and long-term adverse limb outcomes in patients with peripheral artery disease: insights from the REACH registry

DJ Kumbhani, PG Steg, CP Cannon… - European heart …, 2014 - academic.oup.com
Aims Due to a high burden of systemic cardiovascular events, current guidelines
recommend the use of statins in all patients with peripheral artery disease (PAD). We sought …

PORTRAIT (Patient-Centered Outcomes Related to Treatment Practices in Peripheral Arterial Disease: Investigating Trajectories) overview of design and rationale of …

KG Smolderen, K Gosch, M Patel… - … Quality and Outcomes, 2018 - Am Heart Assoc
Background: Health status outcomes, including symptoms, functional status, and quality of
life, are critically important outcomes from patients' perspectives. The PORTRAIT study …

Does diabetes mellitus play a role in restenosis and patency rates following lower extremity peripheral arterial revascularization? A critical overview

KI Paraskevas, DM Baker, A Pompella… - Annals of vascular …, 2008 - Elsevier
Patients with diabetes mellitus (DM) are at increased risk of developing lower extremity
peripheral arterial disease (PAD). The effect of DM on restenosis and patency rates in …

Peripheral arterial disease is prevalent but underdiagnosed and undertreated in the primary care setting in central Greece

C Argyriou, V Saleptsis, S Koutsias… - Angiology, 2013 - journals.sagepub.com
We investigated the prevalence of peripheral arterial disease (PAD). Primary Care Health
Centers (n= 14) in Thessaly (central Greece) recruited 436 participants, mean age 71 (50 …

Renal function impairment in peripheral arterial disease: an important parameter that should not be neglected

KI Paraskevas, AD Giannoukas… - Annals of vascular surgery, 2009 - Elsevier
A considerable percentage of patients with peripheral arterial disease (PAD) have impaired
renal function. We searched the literature (PubMed/Medline) to determine the clinical …

Long-term safety of intramuscular gene transfer of non-viral FGF1 for peripheral artery disease

A Niebuhr, T Henry, J Goldman, I Baumgartner… - Gene therapy, 2012 - nature.com
Peripheral artery disease is a progressive disease. Primary ischemic leg symptoms are
muscle fatigue, discomfort or pain during ambulation, known as intermittent claudication …

[HTML][HTML] Ankle-brachial index use in peripheral vascular interventions for claudication

KE Hawkins, RJ Valentine, JM Duke, Q Wang… - Journal of vascular …, 2022 - Elsevier
Objective The ankle-brachial index (ABI) has been recommended as the first-line
noninvasive test to establish a diagnosis of peripheral arterial disease in patients with …

[图书][B] Routledge international Handbook of nurse education

S Dyson, M McAllister - 2020 - api.taylorfrancis.com
This chapter will provide a brief historical perspective of British nurse education from the
1860s to the present day. From a secular viewpoint this can be dated precisely to the time of …

Are primary care physicians aware of peripheral artery disease risk reduction and management in the Saudi healthcare transformation era? A health cluster …

S Alsheikh, H AlGhofili, OA Alayed, A Aldrak… - …, 2022 - journals.sagepub.com
Introduction Patients with peripheral artery disease (PAD) are often underdiagnosed and
undertreated. This study aimed to assess the knowledge of the recommended target levels …

Long-term outcome of patients with mild intermittent claudication under secondary prevention

Taute, Thommes, Taute, Rapmund, Lindner… - Vasa, 2009 - econtent.hogrefe.com
Background: The known natural history of peripheral arterial disease (PAD) is determined by
the generalization of atherosclerosis with resulting high cardiovascular and cerebrovascular …